Biomarkers, Socioeconomic Factors, and Right Ventricular Function After Surgical Repair for Tetralogy of Fallot

被引:0
作者
Andrea L. Jones
Jennifer Faerber
Jing Huang
Steve Ampah
Yan Wang
Grace DeCost
Monique Gardner
Maryam Y. Naim
Sushma Reddy
Elizabeth Goldmuntz
Laura Mercer-Rosa
机构
[1] Children’s Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine,Division of Cardiology, Department of Pediatrics
[2] Women and Infants Hospital of Rhode Island,Division of Critical Care Medicine, Department of Anesthesia and Critical Care
[3] Children’s Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine,Division of Cardiology, Department of Pediatrics
[4] Lucile Packard Children’s Hospital and Stanford University,undefined
来源
Pediatric Cardiology | 2023年 / 44卷
关键词
Tetralogy of Fallot; Biomarker; Echocardiography; Socioeconomic; Outcome; Heart surgery;
D O I
暂无
中图分类号
学科分类号
摘要
Right ventricular (RV) dysfunction early after tetralogy of Fallot (TOF) increases post-operative morbidity. We investigated associations of circulating biomarkers and socioeconomic factors with early post-operative RV systolic function. Single-center prospective cohort study of infants undergoing TOF repair. Six serologic biomarkers of myocardial fibrosis and wall stress collected at the time of surgery were measured with immunoassay. Geocoding was performed for socioeconomic factors. Multivariate adaptive regression splines (MARS) models identified factors associated with RV function parameters: fractional area change (FAC), global longitudinal strain and strain rate, and free wall strain and strain rate. Seventy-one patients aged 3.5 months (IQR 2.4, 5.2) were included. Galectin-3 was the highest ranked predictor for FAC, global longitudinal strain, and free wall strain, and procollagen type-I carboxy-terminal propeptide (PICP) was the highest ranked predictor for global longitudinal strain rate and free wall strain rate. Several neighborhood characteristics were also highly ranked. Models adjusted R2 ranged from 0.71 to 0.85 (FAC, global longitudinal strain/strain rate), and 0.55–0.57 (RV free wall strain/strain rate). A combination of serologic biomarkers, socioeconomic, and clinical variables explain a significant proportion of the variability in RV function after TOF repair. These factors may inform pre-operative risk-stratification for these patients.
引用
收藏
页码:1232 / 1241
页数:9
相关论文
共 185 条
  • [1] Savla JJ(2019)2-Year outcomes after complete or staged procedure for tetralogy of fallot in neonates J Am Coll Cardiol 74 1570-1579
  • [2] Faerber JA(2020)22q112 deletion syndrome and congenital heart disease Am J Med Genet C 184 64-72
  • [3] Huang YV(2018)Predictors of Length of hospital stay after complete repair for tetralogy of Fallot: a prospective cohort study J Am Heart Assoc 7 5-219
  • [4] Zaoutis T(2014)Predictors of intensive care unit morbidity and midterm follow-up after primary repair of tetralogy of Fallot Korean J Thorac Cardiovasc Surg 47 211-821
  • [5] Goldmuntz E(2021)Identifying Risk factors for complicated post-operative course in tetralogy of Fallot using a machine learning approach Front Cardiovasc Med 8 816-353
  • [6] Kawut SM(2018)Longitudinal changes in right ventricular function in tetralogy of Fallot in the initial years after surgical repair J Am Soc Echocardiogr 31 346-331
  • [7] Goldmuntz E(2015)Distinctive hemodynamics in the immediate postoperative period of patients with a longer cardiac intensive care stay post-tetralogy of Fallot repair Congenit Heart Dis 10 324-700
  • [8] Mercer-Rosa L(2017)NT-proBNP as marker of ventricular dilatation and pulmonary regurgitation after surgical correction of tetralogy of Fallot: a MRI validation study Pediatr Cardiol 38 693-988
  • [9] Elci OU(2014)N-terminal pro-brain natriuretic peptide as a predictor of reoperation in children with surgically corrected tetralogy of fallot Circ J 78 983-1287
  • [10] DeCost G(2006)Brain natriuretic peptide and magnetic resonance imaging in tetralogy with right ventricular dilatation Ann Thorac Surg 82 1279-315